KY 063

Drug Profile

KY 063

Latest Information Update: 06 Mar 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Kyoto Pharmaceutical Industries
  • Class Antiplatelets; Imidazoles; Small molecules; Thrombolytics
  • Mechanism of Action Free radical scavengers; Thromboxane synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Myocardial ischaemia

Most Recent Events

  • 06 Mar 2008 Discontinued - Preclinical for Asthma in Japan (unspecified route)
  • 06 Mar 2008 Discontinued - Preclinical for Myocardial ischaemia in Japan (unspecified route)
  • 06 Jun 2001 No-Development-Reported for Asthma in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top